EHR: THIN Database (European Union): Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
[https://www.cegedim-health-data.com/cegedim-health-data/thin-the-health-improvement-network/] | [https://www.cegedim-health-data.com/cegedim-health-data/thin-the-health-improvement-network/] | ||
''' | '''Primary purpose:''' to provide precise, ethical, and actionable anonymized longitudinal health data for research and medical progress, supporting a range of stakeholders including researchers, healthcare practitioners, and pharmaceutical companies. | ||
''' | '''Sponsor, manager or home institution:''' [[dataOwner::Cegedim Health Data]]. | ||
'''Type of information:''' The database includes groups of variables such as patient interaction data, | '''Type of information:''' The database includes groups of variables such as patient interaction data, [[availableVariable::diagnosis]] information, prescription and [[availableVariable::medical procedures|treatment data]], medical actions and [[availableVariable::check-up examinations|examinations]], [[availableVariable::health record|patient medical history]], measurement and biological data, social and [[availableVariable::region|demographic information]], [[availableVariable::healthcare costs|reimbursement]] and [[availableVariable::sale of medicines|pharmaceutical data]], allergy and sensitivity records, and consolidated health attributes. | ||
'''Data level:''' patient level | '''Data level:''' patient level | ||
Revision as of 16:30, 25 April 2024
Go back to European Union page
Primary purpose: to provide precise, ethical, and actionable anonymized longitudinal health data for research and medical progress, supporting a range of stakeholders including researchers, healthcare practitioners, and pharmaceutical companies.
Sponsor, manager or home institution: Cegedim Health Data.
Type of information: The database includes groups of variables such as patient interaction data, diagnosis information, prescription and treatment data, medical actions and examinations, patient medical history, measurement and biological data, social and demographic information, reimbursement and pharmaceutical data, allergy and sensitivity records, and consolidated health attributes.
Data level: patient level
Number of Records: 69 million.
Cancer Areas of Interest: unknown.
Data access: Data is not publicly available. Instructions to request data for restricted content. [2]
Contact information: Information [3].
